Challenges in using circulating miRNAs as cancer biomarkers.
about
Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell CarcinomaAssessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material.MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?Web-based tools for microRNAs involved in human cancer.Optimization of miRNA-seq data preprocessing.Data Normalization Strategies for MicroRNA Quantification.Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.MicroRNA-146a affects the chemotherapeutic sensitivity and prognosis of advanced gastric cancer through the regulation of LIN52Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire.MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study--A Sub-Study of the Munich Marathon Study).What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme.Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.MicroRNA expression profiles of serum from patients before and after chemotherapy.Urinary miR-16 transactivated by C/EBPβ reduces kidney function after ischemia/reperfusion-induced injury.Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Long non-coding RNAs act as regulators of cell autophagy in diseases (Review).Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.A new function for miRNAs as regulators of autophagy.Translating microRNAs into biomarkers: What is new for pediatric cancer?The choice of endogenous controls in exosomal microRNA assessments from biofluids.Problems, challenges and promises: perspectives on precision medicine.Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR.Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic SyndromeAcute strength training promotes responses in whole blood circulating levels of miR-146a among older adults with type 2 diabetes mellitus.Hunting for the ultimate liquid cancer biopsy - let the TEP dance begin.Role of microRNAs in embryo implantation.Identification of Reference Genes for Analysis of microRNA Expression Patterns in Equine Chorioallantoic Membrane and Serum.Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression.Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue.Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs.Application of Individual qPCR Performance Parameters for Quality Control of Circulating MicroRNA Data.Development of a predictive miRNA signature for breast cancer risk among high-risk women.Epigenetic regulation by DNA methylation and miRNA molecules in cancer.MicroRNAs as biomarkers for clinical studies.Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.
P2860
Q26777900-DAA29CC1-3070-4F03-9313-AF4FCB0FF722Q27301342-DCF6514C-E414-4995-B8C9-D76E185DE160Q28076541-CDB11AE4-960D-490B-BD84-42EC8231E002Q30489440-41989A76-EACA-434E-8345-8D3B9F0173B0Q30936364-8BBCD05F-AE61-4DE5-A04C-63CBFDFE64B4Q30997590-DC5EF063-9E0A-4D1A-A72A-F7CA88233366Q31025891-A3BF3388-2ED9-4681-A40F-1A9A295BF91EQ33598225-9F130144-CB91-4306-ADC2-CD39D5AD492CQ35870894-5A99EEBC-A33E-4F5A-B328-6979BECA94A0Q35918422-DE08E46D-49D0-4EFE-9B2A-9E65CF6E4A11Q35918523-DA70DDDC-AF8B-4316-AD50-452E87B6ABEFQ36267323-207753EA-2391-4B9A-96B6-9A64FEDBD79DQ36332907-D69D2888-0276-46DC-9248-9EB520C22EBCQ37000636-6284C6EA-1489-4513-BA28-ABE6490E3794Q37073022-83F353E8-E3DC-4938-86C4-7C9384957D8DQ37720073-C1833052-10D3-4229-BE51-E9547508CDD3Q38580491-0910EFB8-E0D4-4E0B-A3AA-4C85649F83A5Q38718486-2C5D6352-422C-498B-A80F-351DECCB6DFDQ38783633-E9368C4B-8DFE-43E2-A2A1-42EB67E13FFAQ38810073-578F5619-247B-43B5-9603-909C707D5736Q38903386-6C16D11E-0DED-44D2-AF2C-BB410AC27C0FQ38976902-98361610-D130-4465-83FE-2C95EC523549Q39059921-2ED24162-B15A-4B47-86FF-BD81D40E2F66Q40388823-BB71EE42-D6D2-4223-B558-7FF9191C0B07Q42037071-4B92317A-D0DE-446B-A0D7-7B73D66A6408Q42362062-16B344F4-09FC-4814-98E1-FDC81A5F1E74Q42390300-B6F130A0-835A-43D4-B641-A42957FD23EEQ45376801-73471E7E-FAC7-4AE4-9147-469EFC033157Q46249375-C8882D48-DBE1-4BE9-8693-13907D302A66Q46830133-C800B289-8EAF-4ADD-A41D-085EAD8139D1Q47134018-54C6BAE9-BA37-45D8-B521-0469F1D268EAQ47139209-047DF96F-DB9A-4A73-8371-2E0F26E5A966Q47568240-7DF29328-D55A-43B7-B598-6BB5A512AAEEQ47685860-D631DB80-E5EC-43D8-BA91-3BA34E85993FQ47724615-100CBA90-83AC-4584-BC60-9988FE78770AQ47915829-B24E1231-C926-4720-A6F6-BF43E8EEC486Q47947610-CB8593B5-7DE4-4B10-AA10-5D4078E82851Q48156451-6EEB0F9B-4127-4738-A629-1758350DF124Q48225109-0D1C6931-EE2E-4679-B91D-B89346D523E6Q49212856-4A2F863C-5321-40B4-9582-425BA2A0B23E
P2860
Challenges in using circulating miRNAs as cancer biomarkers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Challenges in using circulating miRNAs as cancer biomarkers.
@en
type
label
Challenges in using circulating miRNAs as cancer biomarkers.
@en
prefLabel
Challenges in using circulating miRNAs as cancer biomarkers.
@en
P2860
P50
P921
P356
P1476
Challenges in using circulating miRNAs as cancer biomarkers.
@en
P2093
Paola Tiberio
Valentina Angeloni
P2860
P304
P356
10.1155/2015/731479
P407
P5008
P577
2015-03-22T00:00:00Z